Gossamer Bio, Inc. (GOSS) has a consensus analyst rating of Buy, based on 17 analysts covering the stock. Of those, 9 recommend buying, 6 recommend holding, and 2 recommend selling.
The analyst consensus price target for GOSS is $0.77, representing a +77.6% upside from the current price of $0.4316. Price targets range from a low of $0.30 to a high of $1.00.
